-
1دورية أكاديمية
المؤلفون: Coppola Nicola, Pisaturo Mariantonietta, Tonziello Gilda, Sagnelli Caterina, Sagnelli Evangelista, Angelillo Italo F
المصدر: BMC Infectious Diseases, Vol 12, Iss 1, p 357 (2012)
مصطلحات موضوعية: Antiviral therapy in HCV patients, Meta-analysis, Response to anti-HCV therapy, Tolerability of anti-HCV therapy, Infectious and parasitic diseases, RC109-216
وصف الملف: electronic resource
-
2
المؤلفون: Nicola Coppola, Caterina Sagnelli, Evangelista Sagnelli, Mariantonietta Pisaturo, Italo F. Angelillo, G. Tonziello
المساهمون: Coppola, N., Pisaturo, M., Tonziello, G., Sagnelli, C., Sagnelli, E., Angelillo, I. F., Coppola, Nicola, Pisaturo, M, Tonziello, G, Sagnelli, Caterina, Sagnelli, E, Angelillo, Italo Francesco
المصدر: BMC Infectious Diseases, Vol 12, Iss 1, p 357 (2012)
BMC Infectious Diseasesمصطلحات موضوعية: Male, medicine.medical_specialty, Alpha interferon, Interferon alpha-2, Polyethylene Glycol, Virus, Polyethylene Glycols, lcsh:Infectious and parasitic diseases, chemistry.chemical_compound, Medical microbiology, Chronic hepatitis, Pegylated interferon, Genotype, medicine, Humans, Meta-analysi, lcsh:RC109-216, Response to anti-HCV therapy, business.industry, Ribavirin, Interferon-alpha, Antiviral therapy in HCV patient, Hepatitis C, Chronic, Recombinant Protein, Virology, Recombinant Proteins, Tolerability of anti-HCV therapy, Meta-analysis, Infectious Diseases, Treatment Outcome, chemistry, Antiviral therapy in HCV patients, Female, business, Research Article, medicine.drug, Human
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db17df2d5c58beeda54594c0845645dTest
http://www.biomedcentral.com/1471-2334/12/357Test -
3دورية أكاديمية
المؤلفون: Coppola, Nicola, Pisaturo, Mariantonietta, Tonziello, Gilda, Sagnelli, Caterina, Sagnelli, Evangelista, Angelillo, Italo F.
المصدر: BMC Infectious Diseases; 2012, Vol. 12 Issue 1, p357-367, 11p, 1 Diagram, 4 Charts, 2 Graphs
مصطلحات موضوعية: GENETIC research, HIV-positive persons, GENETIC polymorphisms, ANTIVIRAL agents, LIVER diseases